|Bid||245.50 x 243000|
|Ask||245.60 x 260500|
|Day's Range||244.60 - 248.50|
|52 Week Range||218.30 - 273.00|
|PE Ratio (TTM)||21.08|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
China has slashed the price of dozens of top drugs from multinationals such as Roche, GSK and AstraZeneca by as much as 70 per cent as a condition of adding them to a government health insurance scheme. ...
The threat to its biologic drugs is still hazy, and it has defenses.
Drugmakers plunged off a patent cliff earlier this decade, losing billions in sales as lucrative branded drugs lost exclusivity. An expensive lobbying effort aimed at preventing a repeat is paying off....